Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction
Language English Country Netherlands Media print
Document type Journal Article
PubMed
29121743
DOI
10.1016/j.ijcard.2017.07.045
PII: S0167-5273(17)32686-4
Knihovny.cz E-resources
- Keywords
- Cardiovascular disease, Fetal growth restriction, Gestational hypertension, Preeclampsia, Pregnancy, microRNA,
- MeSH
- Cerebrovascular Disorders blood diagnostic imaging epidemiology MeSH
- Adult MeSH
- Epigenesis, Genetic physiology MeSH
- Gene Expression MeSH
- Fetal Blood metabolism MeSH
- Hypertension, Pregnancy-Induced blood diagnostic imaging epidemiology MeSH
- Cardiovascular Diseases blood diagnostic imaging epidemiology MeSH
- Cohort Studies MeSH
- Humans MeSH
- MicroRNAs blood genetics MeSH
- Young Adult MeSH
- Pre-Eclampsia blood diagnostic imaging epidemiology MeSH
- Retrospective Studies MeSH
- Fetal Growth Retardation blood diagnostic imaging epidemiology MeSH
- Pregnancy MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Young Adult MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- MicroRNAs MeSH
BACKGROUND AND METHODS: Gene expression of 29 cardiovascular and cerebrovascular disease associated microRNAs was assessed in whole umbilical cord blood, compared between groups [47 gestational hypertension (GH), 56 preeclampsia (PE), 37 fetal growth restriction (FGR) and 44 normal pregnancies] and correlated with the severity of the disease with respect to clinical signs (mild PE vs. severe PE), delivery date (before and after 34weeks of gestation), and Doppler ultrasound parameters [pulsatility index (PI) in the umbilical artery, PI in the middle cerebral artery and the cerebroplacental ratio]. RESULTS: GH showed a down-regulation of miR-195-5p (p=0.025). The down-regulation of miR-26a-5p (p=0.031, p=0.05), miR-145-5p (p=0.042, p=0.015), and miR-574-3p (p=0.002, p=0.022) was observed in severe PE pregnancies requiring termination before 34weeks of gestation. Severe PE occurring regardless of the delivery date was associated with downregulation of miR-195-5p (p=0.01), miR-199a-5p (p=0.048), and miR-221-3p (p=0.028). On the other hand, mild PE showed upregulation of miR-92a-3p (p=0.044). The centralization of fetal circulation tended to higher levels of miR-1-3p (ρ=-0.302, p=0.045) and miR-133a-3p (ρ=-0.348, p=0.020) in PE pregnancies. FGR pregnancies with abnormal values of flow rate in the umbilical artery (miR-221-3p: ρ=-0.390, p=0.017) and the middle cerebral artery (miR-143-3p: ρ=0.350, p=0.036) demonstrated down-regulation of relevant microRNAs. CONCLUSION: Epigenetic changes induced by pregnancy-related complications in umbilical cord blood may appear as a result of dysfunctional placenta and impaired maternal cardiovascular function (hidden cardiovascular and cerebrovascular diseases) and may cause later onset of cardiovascular and cerebrovascular diseases in offspring.
References provided by Crossref.org